American Medical Isotopes Production Act of 2011

[AI summary unavailable — showing source text] American Medical Isotopes Production Act of 2011 - Directs the Secretary of Energy to establish a technology-neutral program to evaluate and support projects for the production in the United States (domestic production), without the use of highly enriched uranium, of significant quantities of molybdenum-99 for medical uses, implemented in cooperation with non-federal entities, the costs of which shall be shared in accordance with certain cost sharing requirements of the Energy Policy Act of 2005. Requires the Secretary to establish a program to make low enriched uranium available, through lease contracts, for irradiation for molybdenum-99 production for medical uses. Amends the Atomic Energy Act of 1954 to: (1) prohibit the Nuclear Regulatory Commission (NRC) from issuing a license for the export of highly enriched uranium from the United States, beginning seven years after enactment of this Act; and (2) authorize an extension of the seven-year period for up to another three years if the Secretary makes specified certifications to appropriate congressional committees. Permits suspension of the export license restriction for a 12-month period if: (1) there is a critical shortage of …